Drug Shortage Report for HEPTOVIR
| Report ID | 18727 |
| Drug Identification Number | 02239194 |
| Brand name | HEPTOVIR |
| Common or Proper name | lamivudine oral solution |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | LAMIVUDINE |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL |
| Packaging size | 240 mL |
| ATC code | J05AF |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2017-08-02 |
| Estimated end date | 2017-09-22 |
| Actual end date | 2017-09-12 |
| Shortage status | Resolved |
| Updated date | 2017-09-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2017-09-13 | French | Compare |
| v3 | 2017-09-13 | English | Compare |
| v2 | 2017-08-10 | French | Compare |
| v1 | 2017-08-10 | English | Compare |
Showing 1 to 4 of 4